Effectiveness of Wearable Device-based Intervention on Glycemic Control in Patients with Type 2 Diabetes: A System Review and Meta-Analysis

2021 ◽  
Vol 46 (1) ◽  
Author(s):  
Jingsong Luo ◽  
Ke Zhang ◽  
Yaxin Xu ◽  
Yanmin Tao ◽  
Qi Zhang
Keyword(s):  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Meta Analysis ◽  
Wearable Device ◽  
System Review

Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

2020 ◽  
Vol 161 ◽  
pp. 105098
Author(s):  
Omid Asbaghi ◽  
Naeini Fatemeh ◽  
Rezaei Kelishadi Mahnaz ◽  
Ghaedi Ehsan ◽  
Eslampour Elham ◽  
...  
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Randomized Controlled Trials ◽  
Meta Analysis ◽  
Controlled Trials ◽  
Randomized Controlled

scholarly journals Self-Management Education for Adults With Type 2 Diabetes: A meta-analysis of the effect on glycemic control

Diabetes Care ◽  
2002 ◽  
Vol 25 (7) ◽  
pp. 1159-1171 ◽  
Author(s):  
S. L. Norris ◽  
J. Lau ◽  
S. J. Smith ◽  
C. H. Schmid ◽  
M. M. Engelgau
Keyword(s):  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Management Education ◽  
Meta Analysis ◽  
Self Management

scholarly journals TheType 2 Deiodinase Thr92Ala PolymorphismIs Associated with Worse Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
Xiaowen Zhang ◽  
Jie Sun ◽  
Wenqing Han ◽  
Yaqiu Jiang ◽  
Shiqiao Peng ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Systematic Review ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glycemic Control ◽  
Meta Analysis ◽  
Increased Risk ◽  
Design And Methods ◽  
Hba1c Levels

Objective. Type 2 deiodinase (Dio2) is an enzyme responsible for the conversion of T4 to T3. The Thr92Ala polymorphism has been shown related to an increased risk for developing type 2 diabetes mellitus (T2DM). The aim of this study is to assess the association between this polymorphism and glycemic control in T2DM patients as marked by the HbA1C levels.Design and Methods.The terms “rs225014,” “thr92ala,” “T92A,” or “dio2 a/g” were used to search for eligible studies in the PubMed, Embase, and Cochrane databases and Google Scholar. A systematic review and meta-analysis of studies including both polymorphism testing and glycated hemoglobin (HbA1C) assays were performed.Results. Four studies were selected, totaling 2190 subjects. The pooled mean difference of the studies was 0.48% (95% CI, 0.18–0.77%), indicating that type 2 diabetics homozygous for the Dio2 Thr92Ala polymorphism had higher HbA1C levels.Conclusions. Homozygosity for the Dio2 Thr92Ala polymorphism is associated with higher HbA1C levels in T2DM patients. To confirm this conclusion, more studies of larger populations are needed.

The effectiveness of pistachio on glycemic control and insulin sensitivity in patients with type 2 diabetes, prediabetes and metabolic syndrome: A systematic review and meta-analysis

2020 ◽  
Vol 14 (5) ◽  
pp. 1589-1595 ◽  
Author(s):  
Peyman Nowrouzi-Sohrabi ◽  
Soheil Hassanipour ◽  
Mohsen Sisakht ◽  
Reza Daryabeygi-Khotbehsara ◽  
Amir Savardashtaki ◽  
...  
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Metabolic Syndrome ◽  
Insulin Sensitivity ◽  
Glycemic Control ◽  
Meta Analysis

Glycemic control and the incidence of neoplasm in patients with type 2 diabetes: a meta-analysis of randomized controlled trials

Endocrine ◽  
2020 ◽  
Vol 70 (2) ◽  
pp. 232-242 ◽  
Author(s):  
Chu Lin ◽  
Xiaoling Cai ◽  
Wenjia Yang ◽  
Fang Lv ◽  
Lin Nie ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Randomized Controlled Trials ◽  
Meta Analysis ◽  
Controlled Trials ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document